Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18996
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFountzilas, G.en
dc.contributor.authorVasilaros, S.en
dc.contributor.authorKoukouras, D.en
dc.contributor.authorMalamos, N.en
dc.contributor.authorPectasides, D.en
dc.contributor.authorAdamou, A.en
dc.contributor.authorNenopoulou, E.en
dc.contributor.authorKiriakou, K.en
dc.contributor.authorZouvani, I.en
dc.contributor.authorKatsohis, K.en
dc.contributor.authorKappas, A.en
dc.contributor.authorSkopa, C.en
dc.contributor.authorSemoglou, C.en
dc.contributor.authorFahantidis, E.en
dc.contributor.authorKonstantaras, C.en
dc.contributor.authorVasilaki, E.en
dc.contributor.authorEconomopoulos, T.en
dc.contributor.authorBacoyiannis, H.en
dc.contributor.authorBafaloukos, D.en
dc.contributor.authorRazi, E.en
dc.contributor.authorPolichronis, A.en
dc.contributor.authorAndroulakis, G.en
dc.contributor.authorPapaioannou, T.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorKosmidis, P.en
dc.contributor.authoret al.,en
dc.date.accessioned2015-11-24T18:56:10Z-
dc.date.available2015-11-24T18:56:10Z-
dc.identifier.issn0250-7005-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18996-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAntineoplastic Combined Chemotherapy Protocols/therapeutic useen
dc.subjectBreast Neoplasms/mortality/*pathology/surgery/*therapyen
dc.subjectChemotherapy, Adjuvanten
dc.subjectCombined Modality Therapyen
dc.subjectDisease-Free Survivalen
dc.subjectEuropeen
dc.subjectFemaleen
dc.subjectGreeceen
dc.subjectHumansen
dc.subjectLymphatic Metastasisen
dc.subjectMedical Recordsen
dc.subjectMenopauseen
dc.subjectMiddle Ageden
dc.subjectMultivariate Analysisen
dc.subjectNeoplasm Stagingen
dc.subjectPrognosisen
dc.subjectReceptors, Estrogen/analysisen
dc.subjectRecurrenceen
dc.subjectRegression Analysisen
dc.subjectRetrospective Studiesen
dc.subjectSurvival Rateen
dc.subjectTamoxifen/therapeutic useen
dc.subjectUnited Statesen
dc.titlePrognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group studyen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/9494589-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1997-
heal.abstractThe independent effects of several patient, tumor and treatment-related prognostic factors on relapse-free survival (RFS) and overall survival (OS) were assessed by Cox multivariate regression analysis in 988 Greek patients with stage II breast cancer. At a median follow-up time of 83 (range 3.3-131+) months and after the evaluation of all patients together, the number of positive axillary nodes (p < 0.0001), tumor size (p = 0.0024) and tumor grade (p = 0.0008) were identified as significant prognostic factors for RFS. Also, the number of positive nodes (p < 0.0001), tumor size (p = 0.0002) and ER status (p = 0.0001) were found to be significant for OS. These short-term prognostic variables are similar to those reported for this group of patients in other European countries and in the USA.en
heal.journalNameAnticancer Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons